12/1/2006 - Fluxion Biosciences Initiates Early Access Program for the BioFlux Shear Force Assay System
System provides automated, precise control of shear for studying biofilms and cellular adhesion San Francisco, CA, December 1, 2006 - Fluxion Biosciences today announced the initiation of early access sales of its BioFlux platform, which provides automated shear force assays for cellular adhesion and biofilm research.

11/10/2006 - Fluxion Biosciences Appoints Jeff Jensen CEO
San Francisco, CA, November 10, 2006 - Fluxion Biosciences, developer of advanced automation solutions for cellular biology, today announced that Jeff Jensen has joined the company as CEO and Director.

4/20/2006 - Fluxion Biosciences Initiates Early Access Program for the IonFux Automated Electrophysiology System
System provides automated solution for performing ion channel assays in drug discovery and development San Francisco, CA, April 20, 2006 - Fluxion Biosciences today announced the initiation of early access sales of its IonFlux platform, which provides automated cellular electrophysiology assays for drug discovery and development.

1/10/2006 - Fluxion Biosciences Receives NIH Grant
January 10, 2006, San Francisco, CA - Fluxion Biosciences, a leading developer of microfluidic systems for cellular assays in life sciences research and drug discovery, today announced that it has received a National Institutes of Health grant for the development of a single-cell electroporation system.